Michelle Cazabat

1.5k total citations
30 papers, 1.2k citations indexed

About

Michelle Cazabat is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Michelle Cazabat has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Virology, 20 papers in Infectious Diseases and 10 papers in Immunology. Recurrent topics in Michelle Cazabat's work include HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (17 papers) and Immune Cell Function and Interaction (9 papers). Michelle Cazabat is often cited by papers focused on HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (17 papers) and Immune Cell Function and Interaction (9 papers). Michelle Cazabat collaborates with scholars based in France, United States and Australia. Michelle Cazabat's co-authors include Jacques Izopet, Pierre Delobel, B. Marchou, Patrice Massip, Christophe Pasquier, Karine Sauné, Maud Mavigner, Stéphanie Raymond, Corinne Souyris and Martine Dubois and has published in prestigious journals such as Journal of Clinical Investigation, Bioinformatics and PLoS ONE.

In The Last Decade

Michelle Cazabat

29 papers receiving 1.2k citations

Peers

Michelle Cazabat
Katherine M. Bruner United States
J J de Jong Netherlands
S. Schnittman United States
Timothy Brennan United States
Elias K. Halvas United States
Daryl Daugherty United States
Jessica C. Engram United States
Katherine M. Bruner United States
Michelle Cazabat
Citations per year, relative to Michelle Cazabat Michelle Cazabat (= 1×) peers Katherine M. Bruner

Countries citing papers authored by Michelle Cazabat

Since Specialization
Citations

This map shows the geographic impact of Michelle Cazabat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Cazabat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Cazabat more than expected).

Fields of papers citing papers by Michelle Cazabat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Cazabat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Cazabat. The network helps show where Michelle Cazabat may publish in the future.

Co-authorship network of co-authors of Michelle Cazabat

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Cazabat. A scholar is included among the top collaborators of Michelle Cazabat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Cazabat. Michelle Cazabat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nayrac, Manon, Nived Collercandy, Mary Réquena, et al.. (2023). Intact proviruses are enriched in the colon and associated with PD-1+TIGIT− mucosal CD4+ T cells of people with HIV-1 on antiretroviral therapy. EBioMedicine. 100. 104954–104954. 7 indexed citations
2.
Nayrac, Manon, Mary Réquena, Michelle Cazabat, et al.. (2020). Th22 cells are efficiently recruited in the gut by CCL28 as an alternative to CCL20 but do not compensate for the loss of Th17 cells in treated HIV-1-infected individuals. Mucosal Immunology. 14(1). 219–228. 8 indexed citations
3.
Raymond, Stéphanie, Nicolas Jeanne, Florence Nicot, et al.. (2019). Long-term evolution of transmitted CXCR4-using HIV-1 under effective antiretroviral therapy. AIDS. 33(13). 1977–1985. 1 indexed citations
4.
Dimeglio, Chloé, Stéphanie Raymond, Nicolas Jeanne, et al.. (2019). THETA: a new genotypic approach for predicting HIV-1 CRF02-AG coreceptor usage. Bioinformatics. 36(2). 416–421. 4 indexed citations
5.
Raymond, Stéphanie, Florence Nicot, Nicolas Jeanne, et al.. (2017). Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use. Scientific Reports. 7(1). 42215–42215. 9 indexed citations
6.
Raymond, Stéphanie, Florence Nicot, Romain Carcenac, et al.. (2016). No selection of CXCR4-using variants in cell reservoirs of dual-mixed HIV-infected patients on suppressive maraviroc therapy. AIDS. 30(6). 965–968.
7.
Réquena, Mary, Maud Mavigner, Michelle Cazabat, et al.. (2016). CCR6− regulatory T cells blunt the restoration of gut Th17 cells along the CCR6–CCL20 axis in treated HIV-1-infected individuals. Mucosal Immunology. 9(5). 1137–1150. 32 indexed citations
8.
Jeanne, Nicolas, Adrien Saliou, Romain Carcenac, et al.. (2015). Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism. Scientific Reports. 5(1). 16944–16944. 8 indexed citations
9.
Raymond, Stéphanie, Adrien Saliou, Pierre Delobel, et al.. (2014). Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 69(9). 2527–2530. 16 indexed citations
10.
Delobel, Pierre, Michelle Cazabat, Adrien Saliou, et al.. (2013). Primary resistance of CCR5-tropic HIV-1 to maraviroc cannot be predicted by the V3 sequence. Journal of Antimicrobial Chemotherapy. 68(11). 2506–2514. 9 indexed citations
11.
Chapuy‐Regaud, Sabine, Caroline Subra, Mary Réquena, et al.. (2013). Progesterone and a phospholipase inhibitor increase the endosomal bis(monoacylglycero)phosphate content and block HIV viral particle intercellular transmission. Biochimie. 95(9). 1677–1688. 22 indexed citations
12.
Raymond, Stéphanie, Pierre Delobel, Marie‐Laure Chaix, et al.. (2011). Genotypic prediction of HIV-1 subtype D tropism. Retrovirology. 8(1). 56–56. 36 indexed citations
13.
Mavigner, Maud, Michelle Cazabat, Martine Dubois, et al.. (2011). Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals. Journal of Clinical Investigation. 122(1). 62–69. 127 indexed citations
14.
Raymond, Stéphanie, Pierre Delobel, Maud Mavigner, et al.. (2010). CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression. AIDS. 24(15). 2305–2312. 65 indexed citations
15.
Raymond, Stéphanie, Pierre Delobel, Maud Mavigner, et al.. (2009). Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage. Journal of Clinical Virology. 47(2). 126–130. 53 indexed citations
16.
Mavigner, Maud, Pierre Delobel, Michelle Cazabat, et al.. (2009). HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy. PLoS ONE. 4(10). e7658–e7658. 103 indexed citations
17.
Raymond, Stéphanie, Pierre Delobel, Maud Mavigner, et al.. (2008). Correlation between genotypic predictions based on V3 sequences and phenotypic determination of HIV-1 tropism. AIDS. 22(14). F11–F16. 102 indexed citations
18.
Delobel, Pierre, Karine Sauné, Michelle Cazabat, et al.. (2005). Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART. AIDS. 19(16). 1739–1750. 75 indexed citations
19.
Delobel, Pierre, Karine Sauné, Michelle Cazabat, et al.. (2005). R5 to X4 Switch of the Predominant HIV-1 Population in Cellular Reservoirs During Effective Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 38(4). 382–392. 94 indexed citations
20.
Pasquier, Christophe, Richard Njouom, Karine Sandres, et al.. (2001). HIV-1 subtyping using phylogenetic analysis of pol gene sequences. Journal of Virological Methods. 94(1-2). 45–54. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026